Loading insider details...
Beta
Latest Form 4 (Jun 3, 2026): Disposition to Issuer of 100,000 CHRS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 3, 2026 | Coherus Oncology, Inc. (CHRS) | Disposition to Issuer | 100,000 | n/a |
| Jan 26, 2026 | Coherus Oncology, Inc. (CHRS) | Grant/Award | 112,500 | n/a |
| Jan 23, 2026 | Coherus Oncology, Inc. (CHRS) | Tax Withholding | 1,715 | $2.7K |
| May 9, 2025 | Coherus BioSciences, Inc. (CHRS) | Grant/Award | 200,000 | n/a |
| Jan 23, 2025 | Coherus BioSciences, Inc. (CHRS) | Tax Withholding | 1,711 | $2.4K |
| Jan 10, 2025 | Coherus BioSciences, Inc. (CHRS) | Tax Withholding | 1,711 | $2.7K |
| Jan 8, 2025 | Coherus BioSciences, Inc. (CHRS) | Grant/Award | 160,000 | n/a |
| Aug 9, 2024 | Coherus BioSciences, Inc. (CHRS) | Grant/Award | 75,000 | n/a |
| Jan 24, 2024 | Coherus BioSciences, Inc. (CHRS) | Tax Withholding | 1,707 | $4.2K |
| Jan 10, 2024 | Coherus BioSciences, Inc. (CHRS) | Tax Withholding | 1,707 | $4.9K |